REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/26/2026
Back to search
Official data from USPTO
BIOHALE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
01/27/2026
Trademark type
Word
Nice classes
1, 5
Filing date
03/25/2020
Registration date
01/26/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/26/2021
Last transaction
01/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
O'BRIEN, ELIZABETH A
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DFE Pharma GmbH & Co. KG
FrieslandCampina Nederland B.V.
Representatives
Roberto Ledesma Law Office of Roberto Ledesma
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and organic excipients for use in the manufacture of pharmaceutical preparations; chemical and organic compositions for use in the manufacture of pharmaceuticals; enzymes in the nature of saccharides for use in the pharmaceutical industry; carbonic hydrates for pharmaceutical purposes; amino acids for laboratory or research use; amino acids for industrial purposes
Class 5
Pharmaceuticals for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; biological preparations for pharmaceutical purposes for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; biological preparations for medical purposes for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; hyaluronic acids for pharmaceutical purposes; hyaluronic acids for medical purposes; amino acids for pharmaceutical purposes; amino acids for medical purposes; lactose for pharmaceutical purposes
Publications
History of USPTO decisions and trademark events.
28 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/13/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/30/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/30/2021
FIMP
FINAL DISPOSITION PROCESSED
04/30/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2020
PUBO
PUBLISHED FOR OPPOSITION
11/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/21/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
10/01/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/01/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
10/01/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2020
RFNT
REFUSAL PROCESSED BY IB
08/07/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/22/2020
RFRR
REFUSAL PROCESSED BY MPU
07/22/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/17/2020
CNRT
NON-FINAL ACTION WRITTEN
06/16/2020
DOCK
ASSIGNED TO EXAMINER
06/16/2020
MAFR
APPLICATION FILING RECEIPT MAILED
05/26/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/22/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/21/2020
Continuous trademark protection
Get notified about every new filing that threatens BIOHALE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.